Heerma Peter 4
4 · Travere Therapeutics, Inc. · Filed Nov 4, 2025
Insider Transaction Report
Form 4
Heerma Peter
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Common Stock
2025-10-31$35.00/sh−5,591$195,685→ 119,071 total - Gift
Common Stock
2025-11-03−1,078→ 117,993 total
Footnotes (2)
- [F1]This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
- [F2]This transaction represents a charitable gift of 1,078 shares of common stock to a donor advised fund, which was gifted pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.